Stay updated on Comparison of Insulin Glargine in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Comparison of Insulin Glargine in Type 2 Diabetes Clinical Trial page.

Latest updates to the Comparison of Insulin Glargine in Type 2 Diabetes Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. The previous revision label v3.4.2 was removed.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no substantive changes to the study details, eligibility criteria, or results are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page now shows a revision banner with Revision: v3.4.1, replacing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded a Show glossary option and updated metadata with 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the previous capitalization and version text.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check88 days agoChange DetectedThe locations list was updated to replace many U.S. sites with international sites (Gauteng, KwaZulu-Natal, Western Cape, Gyeonggi-do); revision: v3.3.3.SummaryDifference2%

Stay in the know with updates to Comparison of Insulin Glargine in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Insulin Glargine in Type 2 Diabetes Clinical Trial page.